Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385695655> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4385695655 endingPage "230.04" @default.
- W4385695655 startingPage "230.04" @default.
- W4385695655 abstract "Abstract Intratumoral heterogeneity (ITH) – cellular and molecular diversity within a tumor – is linked to failure of immunotherapy in multiple cancer types. A high degree of ITH is associated with poor infiltration of T cells into the tumor and resistance to immune checkpoint blockade (ICB) therapy. To determine how distinct tumor populations within heterogeneous tumors shape the immune microenvironment and how this impacts therapy response, we modeled heterogeneous tumors composed of an RFP-tagged immunosuppressive tumor population and a YFP-tagged pro-inflammatory tumor population. The resulting tumors contained a patchwork of distinct regions with YFP +cells, RFP +cells, or a mixture of YFP +and RFP +cells. Analysis of the immune infiltrates in each region revealed a higher frequency of total CD4 T cells, Th1 cells and IFNg +CD8 T cells in YFP regions compared to RFP regions, whereas macrophages exhibited the opposite pattern. PD-1 blockade and CD40 agonist combinatorial antibody therapy induced an increase in Th1 abundance in RFP regions, but the treatment did not clear the tumors. Together, these results reveal that distinct regional immune infiltration pattens within the tumor are driven by the local tumor cells present in each region, and that the treatment-induced global improvement of Th1 infiltration alone is not sufficient to induce tumor clearance. Moreover, we identified Cx3cl1 as a driver of a dominant immunosuppressive tumor microenvironment, marked by an increase in immunosuppressive CD206 +macrophages and decrease in anti-tumoral neutrophils and monocytes. These results suggest that an immunosuppressive tumor population drives immunotherapy resistance of heterogeneous tumors and Cx3cl1 as a new therapeutic target. Supported by grants from Parker Institute for Cancer Immunotherapy (Project Grant)" @default.
- W4385695655 created "2023-08-10" @default.
- W4385695655 creator A5012565486 @default.
- W4385695655 creator A5013943962 @default.
- W4385695655 creator A5015964712 @default.
- W4385695655 creator A5018179968 @default.
- W4385695655 creator A5024307786 @default.
- W4385695655 creator A5030109235 @default.
- W4385695655 creator A5031997708 @default.
- W4385695655 creator A5055296283 @default.
- W4385695655 creator A5059531375 @default.
- W4385695655 date "2023-05-01" @default.
- W4385695655 modified "2023-09-23" @default.
- W4385695655 title "An immunosuppressive tumor population drives immunotherapy resistance of heterogeneous tumors" @default.
- W4385695655 doi "https://doi.org/10.4049/jimmunol.210.supp.230.04" @default.
- W4385695655 hasPublicationYear "2023" @default.
- W4385695655 type Work @default.
- W4385695655 citedByCount "0" @default.
- W4385695655 crossrefType "journal-article" @default.
- W4385695655 hasAuthorship W4385695655A5012565486 @default.
- W4385695655 hasAuthorship W4385695655A5013943962 @default.
- W4385695655 hasAuthorship W4385695655A5015964712 @default.
- W4385695655 hasAuthorship W4385695655A5018179968 @default.
- W4385695655 hasAuthorship W4385695655A5024307786 @default.
- W4385695655 hasAuthorship W4385695655A5030109235 @default.
- W4385695655 hasAuthorship W4385695655A5031997708 @default.
- W4385695655 hasAuthorship W4385695655A5055296283 @default.
- W4385695655 hasAuthorship W4385695655A5059531375 @default.
- W4385695655 hasBestOaLocation W43856956551 @default.
- W4385695655 hasConcept C153400128 @default.
- W4385695655 hasConcept C159985019 @default.
- W4385695655 hasConcept C167672396 @default.
- W4385695655 hasConcept C192562407 @default.
- W4385695655 hasConcept C203014093 @default.
- W4385695655 hasConcept C2776107976 @default.
- W4385695655 hasConcept C2777701055 @default.
- W4385695655 hasConcept C2780851360 @default.
- W4385695655 hasConcept C2908647359 @default.
- W4385695655 hasConcept C502942594 @default.
- W4385695655 hasConcept C71924100 @default.
- W4385695655 hasConcept C86803240 @default.
- W4385695655 hasConcept C8891405 @default.
- W4385695655 hasConcept C99454951 @default.
- W4385695655 hasConceptScore W4385695655C153400128 @default.
- W4385695655 hasConceptScore W4385695655C159985019 @default.
- W4385695655 hasConceptScore W4385695655C167672396 @default.
- W4385695655 hasConceptScore W4385695655C192562407 @default.
- W4385695655 hasConceptScore W4385695655C203014093 @default.
- W4385695655 hasConceptScore W4385695655C2776107976 @default.
- W4385695655 hasConceptScore W4385695655C2777701055 @default.
- W4385695655 hasConceptScore W4385695655C2780851360 @default.
- W4385695655 hasConceptScore W4385695655C2908647359 @default.
- W4385695655 hasConceptScore W4385695655C502942594 @default.
- W4385695655 hasConceptScore W4385695655C71924100 @default.
- W4385695655 hasConceptScore W4385695655C86803240 @default.
- W4385695655 hasConceptScore W4385695655C8891405 @default.
- W4385695655 hasConceptScore W4385695655C99454951 @default.
- W4385695655 hasIssue "1_Supplement" @default.
- W4385695655 hasLocation W43856956551 @default.
- W4385695655 hasOpenAccess W4385695655 @default.
- W4385695655 hasPrimaryLocation W43856956551 @default.
- W4385695655 hasRelatedWork W1996150995 @default.
- W4385695655 hasRelatedWork W2563663251 @default.
- W4385695655 hasRelatedWork W2598516816 @default.
- W4385695655 hasRelatedWork W2898379310 @default.
- W4385695655 hasRelatedWork W3028822667 @default.
- W4385695655 hasRelatedWork W3197243161 @default.
- W4385695655 hasRelatedWork W3217412908 @default.
- W4385695655 hasRelatedWork W4281389645 @default.
- W4385695655 hasRelatedWork W4286629873 @default.
- W4385695655 hasRelatedWork W4304979265 @default.
- W4385695655 hasVolume "210" @default.
- W4385695655 isParatext "false" @default.
- W4385695655 isRetracted "false" @default.
- W4385695655 workType "article" @default.